It’s hard to get much better than this sentiment-wise, says John Hancock’s Emily RolandAugust 13, 2025
It’s hard to get much better than this sentiment-wise, says John Hancock’s Emily RolandAugust 13, 2025
Fed Rate Cut Bets Increased, Putin Heads to Trump Summit in Alaska | The Opening Trade 8/13August 13, 2025
Global Stocks Gain On Inflation Data, CoreWeave Disappoints On AI Costs | The Pulse 8/13/2025August 13, 2025
Share Facebook Twitter LinkedIn Pinterest Email China was once notorious for knockoff drugs, but the country’s biotech companies are advancing ferociously, eclipsing the EU and catching up to the US. Here’s how Chinese drugmakers are challenging Western dominance on innovation.